Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cashflow Statement

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹2,916 Cr₹2,163 Cr₹2,369 Cr₹3,684 Cr₹2,666 Cr
Adjustment ₹115 Cr₹81 Cr₹144 Cr₹240 Cr₹189 Cr
Changes In working Capital ₹-554 Cr₹-607 Cr₹419 Cr₹-1,370 Cr₹-264 Cr
Cash Flow after changes in Working Capital ₹2,477 Cr₹1,637 Cr₹2,932 Cr₹2,553 Cr₹2,591 Cr
Cash Flow from Operating Activities ₹1,653 Cr₹1,261 Cr₹2,459 Cr₹1,912 Cr₹1,947 Cr
Cash Flow from Investing Activities ₹-804 Cr₹-269 Cr₹-2,707 Cr₹-2,195 Cr₹75 Cr
Cash Flow from Financing Activities ₹-799 Cr₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr
Net Cash Inflow / Outflow ₹50 Cr₹193 Cr₹-1,045 Cr₹-816 Cr₹1,987 Cr
Opening Cash & Cash Equivalents ₹363 Cr₹170 Cr₹1,215 Cr₹2,030 Cr₹43 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹413 Cr₹363 Cr₹170 Cr₹1,215 Cr₹2,030 Cr

Compare Cashflow Statement of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹163,885.2 Cr 1.9% -6.7% 0.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics
MANKIND PHARMA ₹85,533.2 Cr -0.9% -5.8% -18.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

1.9%

-6.7%

0.4%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses